Doctor profile · Federal record

Dr. James Sutherland, M.D.

Rheumatology Physician · Mechanicsville, VA

  • NPI 1467458232
  • MIPS 53.0 / 100 · 2023
  • 21 yrs on file
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
8201 Atlee RD, Ste B
Mechanicsville, VA 231161815
(804) 730-5222
fax (804) 730-5225
Mailing address
1401 Johnston Willis Dr, Ste 1200
Richmond, VA 232354730

Credentials & registration

NPPES · NUCC
NPI registered
June 2005 — 21 yrs on file
Profile last updated
August 26, 2014
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Virginia #0101040477
Medicaid
VA #5837707

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1467458232. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
45,777
Distinct HCPCS
10
Medicare allowed
$633,469
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 34,400 18 $5
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 4,825 15 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 4,760 13 $33
99213 Established patient office or other outpatient visit, 20-29 minutes 375 155 $88
96413 Administration of chemotherapy into vein, 1 hour or less 212 41 $129
J7050 Infusion, normal saline solution, 250 cc 212 41 $1
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 178 21 $72
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 164 22 $1
J1040 Injection, methylprednisolone acetate, 80 mg 122 51 $11
36415 Insertion of needle into vein for collection of blood sample 113 31 $3

In context: peer comparison

Among 3 peers in Mechanicsville Rheumatology Physician, average services per provider: 5,960. This provider delivers 7.7× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$189
Transactions
9
Manufacturers
7
Payer (manufacturer) Industry Txns Amount
Amgen INC. 2 $41.61
Abbvie INC. 2 $39.86
Novartis Pharmaceuticals Corporation 1 $27.96
Ucb, INC. 1 $22.03
Pfizer INC. 1 $20.78
Sandoz INC. 1 $20.22
Actelion Pharmaceuticals US, INC. 1 $16.20

By nature of payment

Food and Beverage
$189

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,501
Patients
297
Total drug cost
$49,124
Drug Type Claims Patients Total cost
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 258 38 $13,018
Prednisone Generic 190 54 $1,744
Oxycodone Hcl Generic 187 23 $8,518
Gabapentin Generic 175 41 $4,016
Methotrexate (Methotrexate Sodium) Brand 163 35 $5,253
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 123 17 $7,694
Tramadol Hcl Generic 116 26 $1,338
Pregabalin Generic 56 19 $2,852
Zolpidem Tartrate Generic 51 0 $608
Hydroxychloroquine Sulfate Generic 44 15 $2,350

Frequently asked questions

Auto-generated from federal data
What is Dr. James Sutherland's medical specialty?
Dr. James Sutherland practices Rheumatology Physician in Mechanicsville, VA.
Where does Dr. James Sutherland practice?
Dr. James Sutherland practices at 8201 Atlee RD, Mechanicsville, VA 231161815. Office phone: 8047305222.
What is Dr. James Sutherland's NPI?
Dr. James Sutherland's National Provider Identifier (NPI) is 1467458232, issued by NPPES.
What procedures does Dr. James Sutherland commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.